Kirjallisuus - literature

mariPOC®-hengitystieinfektiotesteihin liittyvät

Tieteelliset julkaisut (tärkeimmät)

A dual antigen-antibody test from a nasopharyngeal sample is a new tool for the clinical evaluation of SARS-CoV-2. Nuttens J, Juusela M, Antikainen, P1, Koskinen, J.M.1, Koskinen J.O. Virology days 2024. Poster #53

Clinical evaluation of an automated, rapid mariPOC® antigen test in screening of symptomatics and asymptomatics for SARS-CoV-2 infection. Gunell M, Rantasärkkä K, Arjonen R, Sandén A, Vuorinen T. J Med Virol. 2022;10.1002/jmv.28189.

The evaluation of an automated mariPOC SARS-CoV-2 antigen test compared to RT-qPCR SARS-CoV-2 assay and comparison of its sensitivity in Delta- and Omicron-variant samples. Krutova, M, Brajerova, M, Kepka, Z, Briksi, A, Hubacek, P, Drevinek, P. Influenza Other Respi Viruses. 2022; 1- 7.

Nasal swab sampling for antigen test identifies COVID-19 well in all ages. Juusela, M, et al. European Respiratory Society (ERS) International Congress, September 2022. Barcelona, Spain. Abstract (#32395) and poster #PA860.

Comparison of SARS-CoV-2 nucleocapsid antigen levels and in-house PCR Ct values in nasopharyngeal swab samples. Antikainen, P, et al. 32nd European Congress of Clinical Microbiology and Infectious Diseases, April 2022. Abstract (#03579) and poster #P2101.

Quantitative comparison of viral loads in self-sampled nasal and nasopharyngeal swab samples over the course of COVID-19 infection. Nuttens, J, et al. 32nd European Congress of Clinical Microbiology and Infectious Diseases, April 2022. Abstract (#04971) and poster L0418.

Clinical validation of automated and rapid mariPOC SARS-CoV-2 antigen test. Koskinen, JM et al. Scientific reports. (2021) vol. 11:20363. 

Oseltamivir treatment of influenza A and B infections in infants. Mattila JM, et al.
Influenza and Other Respiratory Viruses. (2021) 15:618–624.

Monitoring of SARS-CoV-2 infection from nasopharyngeal swab, saliva, feces and urine by a quantitative rapid antigen test. Nuttens, J, et al. 37th Annual meeting of the Nordic Society of Clinical Microbiology and Infectious Diseases (NSCMID) 2021, Turku, Suomi. Tieteellinen tiivistelmä ja posteri #39.

Prospective evaluation of a new mariPOC respi test with improved sensitivity for influenza A virus. Thomas E, et al. 28th European Congress of Clinical Microbiology and Infectious Diseases 2019, Amsterdam, Alankomaat. Tieteellinen tiivistelmä #2977 ja posteri #P0114.

Comparison of phenotypic and genotypic diagnosis of acute human bocavirus 1 infection in children. Kols NI, et al. J Clin Virol. 2019;120:17–19.

Rapid detection and monitoring of human coronavirus infections. Bruning AH, et al. New Microbes New Infect. 2018;24:52–55.

Development and validation of a new mariPOC influenza A virus test with enhanced sensitivity. Antikainen P, et al. 27th European Congress of Clinical Microbiology and Infectious Diseases 2017, Wien, Itävalta. Tieteellinen tiivistelmä #4575 ja posteri #P0910.

New QuickStrepA test of automated mariPOC® system provides culture sensitivity in 15 minutes. Antikainen P, et al. 34th annual meeting of NSCMID 2017, Tórshavn, Färsaaret, Tanska. Tieteellinen tiivistelmä ja posteri #PP02.36.

Detection and monitoring of Human Bocavirus 1 infection by a new rapid antigen test. Bruning AH, et al. New Microbes New Infect. 2016;11:17–19.

Analytical performance of the automated multianalyte point-of-care mariPOC® for the detection of respiratory viruses. Sanbonmatsu-Gámez S, et al. Diagn Microbiol Infect Dis. 2015;83:252–256.

Detection of Group A Streptococcus from Pharyngeal Swab Samples by Bacterial Culture is Challenged by a Novel mariPOC Point-of-Care Test. Vakkila J, et al. J Clin Microbiol. 2015;53:2079–2083.

Comprehensive real-time epidemiological data from respiratory infections in Finland between 2010 and 2014 obtained from an automated and multianalyte mariPOC® respiratory pathogen test. Gunell M et al. Eur J Clin Microbiol Infect Dis. 2016;35:405–13.

Evaluation of the Automated Multianalyte Point-of-Care mariPOC® Test for the Detection of Influenza A Virus and Respiratory Syncytial Virus. Tuuminen T, et al. J Med Virol. 2013;85:1598–1601.

Identification of Respiratory Viruses with a Novel Point-of-Care Multianalyte Antigen Detection Test in Children with Acute Respiratory Tract Infection. Ivaska L, et al. J Clin Virol. 2013;57:136–140.

Performance Evaluation of Multianalyte mariPOC® Respiratory Infection Test for Adenovirus Types 1-8, 14, 19 and 21. Koskinen JO, et al. 22nd European Congress of Clinical Microbiology and Infectious Diseases 2012, Lontoo, Iso-Britannia. Tieteellinen tiivistelmä R2630.

Rapid Method for Detection of Influenza A and B Virus Antigens by Use of a Two-Photon Excitation Assay Technique and Dry-Chemistry Reagents. Koskinen JO, et al. J Clin Microbiol. 2007;45:3581–3588.

Variation of coronavirus OC43 results in recurrent infections. Koskinen JM, et al. Virologipäivät 2018, Tuusula, Suomi. Suullinen esitys ja tieteellinen tiivistelmä #9.

Automated mariPOC® platform enables highly sensitive and rapid antigen detection and subtyping of influenza viruses. Antikainen P, et al. Trends in Influenza Research 2017, Pietari, Venäjä. Suullinen esitys ja tieteellinen tiivistelmä O23, sivut 71–73.

Toimitukselliset julkaisut

Diagnostic test gets a positive result (PPC Dec 2015)

Interview of Pentti Huovinen, dean of medicine, University of Turku, Finland: Rapid Detection of Strep A (PPC Nov 2015)

Respiratory infection management requires high specificity tests (PPC, Nov 2015)

A new diagnostic tool for process improvements (PPC, July 2015)

Time to set new standard in GAS testing (PPC, April 2015)